Analysis of multiple-dose bioequivalence studies

DOI10.1080/10543409408835093zbMATH Open0925.62479OpenAlexW1968116286WikidataQ52366950 ScholiaQ52366950MaRDI QIDQ4216072FDOQ4216072

Authors: Vernon M. Chinchilli, James D. Esinhart, William H. Barr 

Publication date: 18 November 1999

Published in: Journal of Biopharmaceutical Statistics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/10543409408835093

Recommendations

• A More Powerful Average Bioequivalence Analysis for the 2 × 2 Crossover
• The multivariate assessment of bioequivalence
• scientific article; zbMATH DE number 747024
• Statistical considerations in bioequivalence trials

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Design of statistical experiments (62K99)

Cites Work

• Recovery of inter-block information when block sizes are unequal
• Title not available (Why is that?)
• The Subject-by-Formulation Interaction as a Criterion of Interchangeability of Drugs

Cited In (9)

• Quasi-Likelihood Approach to Bioavailability and Bioequivalence Analysis
• A More Powerful Average Bioequivalence Analysis for the 2 × 2 Crossover
• Statistical evaluation of individual bioequivalence
• Title not available (Why is that?)
• Assessing systemic drug exposure in repeated dose toxicity studies in the case of complete and incomplete sampling
• Multivariate Slope Ratio Assay with Repeated Measurements
• Evaluation of log-transformation in assessing bioequivalence
• Analysis of adverse events in titration studies.
• Statistical considerations in bioequivalence of two area under the concentration-time curves obtained from serial sampling data

Uses Software

• SAS

This page was built for publication: Analysis of multiple-dose bioequivalence studies

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4216072)